Clinical trial
A Randomized, Partially Double-blind, Controlled, Multi-center Clinical Study of Wulingsan Single Decoction Granules Combined With Conventional Therapy in the Treatment of Metabolic Syndrome of Spleen Deficiency, Dampness and Sleepiness
NCT04812236 is registered in ClinicalTrials.gov with Jiangsu Famous Medical Technology Co., Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized, Partially Double-blind, Controlled, Multi-center Clinical Study of Wulingsan Single Decoction Granules Combined With Conventional Therapy in the Treatment of Metabolic Syndrome of Spleen Deficiency, Dampness and Sleepiness
- Lead sponsor
- Jiangsu Famous Medical Technology Co., Ltd.
- Phase
- Phase 4
- Overall status
- Unknown status
- Start date
- April 1, 2021
- Completion date
- May 1, 2023
- Enrollment
- 320 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.